GeneReach Biotechnol...
TPEX:4171
NT$ 17,35
NT$-0,95 (-5,19%)
End-of-day quote: 10/14/2026
17,35 NT$
NT$-0,95 (-5,19%)
End-of-day quote: 10/14/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

G
0%
3-year Growth Rate
R
4/6
3-year Risk Analysis
O
0%
Outlook 12/24
W
N/A
Margin of safety
T
-100%
Analyst Price Target
H
UP
50-week EMA Trend

Company Info

EPS Growth 3Y
0,00%
Revenue growth 3Y
0,00%
Price growth 3Y
-46,78%
Market Cap
NT$0,99 B
Long-Term Debt
NT$0,02 B
Quarterly earnings
11/12/2026
Dividend
NT$0,00
Dividend Yield
0,00%
Industry
Country
ISIN Number

GeneReach Biotechnology Price Chart (TWD)

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

There are currently no price targets available for this stock.

Top growth stocks in the health care sector

Stock Rate of Return 5Y Price 5Y Div. 5Y G R O W T H
GeneReach Biotechnology
TPEX:4171
-62,10% -71,22% 9,12% 0,00% 4/6 0,00% 0,00% -100,00% UP

Financials

Profile

Competitors

News

×